This is a service of EIN News a digital news provider
Healthcare Industry Today
Sign up for a free trial
Register Now
Member center Log In
Abacavir News is an EIN News Service for health professionals. Constantly updated news and information about health.
FORMATS: RSS | EMAIL

Latest Abacavir News

Sort by: relevance (24 hours) relevance date
  • GSK drops drug prices for poor nations 6 Nov 2009 05:33 GMT
    ... United Kingdom-based GlaxoSmithKline (GSK), the world's second-largest drug company, announced a radical change in its ... formulations for children and new fixed-dose combination treatments. We desperately need these and a patent ... licensing policy to include the second-line ARV abacavir on a royalty-free basis; and A commitment ...

  • ViiV Healthcare launches: A new specialist HIV company dedicated to delivering advances in HIV treatment and care 4 Nov 2009 17:13 GMT
    ... company dedicated to delivering advances in HIV treatment and care LONDON, 3 November 2009 --Today, ... available including therapies such as Epzicom /Kivexa (abacavir sulfate+lamivudine) and Selzentry /Celsentri (maraviroc). Revenues from ... regarding whether and when to approve any drug applications that have been or may be ...

  • A new specialist HIV company dedicated to delivering advances in HIV treatment and care 4 Nov 2009 16:55 GMT
    ... company dedicated to delivering advances in HIV treatment and care CEO promises ‘relentless pursuit’ of ... currently available including therapies such as Epzicom/Kivexa (abacavir sulfate+lamivudine) and Selzentry/Celsentri (maraviroc). Revenues from these ... Healthcare had the potential to “re-energise” the pharmaceutical industry’s participation in HIV. He emphasised the ...

  • GSK and Pfizer launch joint HIV venture, ViiV Healthcare 4 Nov 2009 09:17 GMT
    ... The pharmaceutical companies GlaxoSmithKline and Pfizer announced today that ... has a 19% share of the global drugs market, in comparison to Gilead’s 31%. GlaxoSmithKline (GSK) ... The licensed drugs include GSK’s combination pills (abacavir and 3TC). Pfizer’s sole licensed anti-HIV drug ...

  • GSK and Pfizer launch joint venture, ViiV Healthcare 3 Nov 2009 16:51 GMT
    ... The pharmaceutical companies GlaxoSmithKline and Pfizer announced today that ... has a 19% share of the global drugs market, in comparison to Gilead’s 31%. GlaxoSmithKline (GSK) ... The licensed drugs include GSK’s combination pills (abacavir and 3TC). Pfizer’s sole licensed anti-HIV drug ...

  • GSK/Pfizer HIV venture ViiV is launched 4 Nov 2009 12:15 GMT
    ... products on the market, including GSK’s Kivexa (abacavir and lamivudine) and Pfizer’s new oral drug Selzentry/Celsentri (maraviroc). Revenues from these generated sales ... that “rising infection rates and increasingly complex treatment issues have created a challenging landscape in ...

  • GSK and Pfizer partner to treat HIV 3 Nov 2009 15:17 GMT
    ... (GSK) and Pfizer to deliver advances in treatment and care for people living with HIV, ... currently available including therapies such as Epzicom/Kivexa (abacavir sulfate and lamivudine) and Selzentry/Celsentri (maraviroc). Revenues ... Healthcare had the potential to "re-energise" the pharmaceutical industry’s participation in HIV. He emphasised the ...

  • GlaxoSmithKline, Pfizer Launches Specialist HIV Company 3 Nov 2009 09:33 GMT
    ... LONDON -(Dow Jones)- Pharmaceutical companies GlaxoSmithKline (GSK) and Pfizer (PFE) said ... company dedicated to delivering advances in HIV treatment and care. -To tackle increasingly diverse and ... currently available including therapies such as Epzicom/Kivexa (abacavir sulfate+lamivudine) and Selzentry/Celsentri ( maraviroc). -Revenues from ...

  • GlaxoSmithKline Launches Specialist HIV Company 3 Nov 2009 18:16 GMT
    ... LONDON -(Dow Jones)- Pharmaceutical companies GlaxoSmithKline (GSK) and Pfizer (PFE) said ... company dedicated to delivering advances in HIV treatment and care. -To tackle increasingly diverse and ... currently available including therapies such as Epzicom/Kivexa (abacavir sulfate+lamivudine) and Selzentry/Celsentri (maraviroc). -Revenues from these ...

  • Interim data from Bristol-Myers Squibb's BARACLUDE study for chronic hepatitis B patients 2 Nov 2009 10:16 GMT
    ... Bristol-Myers Squibb today announced 48-week data from an ... precore or H... 4SC AG, the German drug discovery and development company, today announced the ... first p... For patients on dialysis, taking medications to reduce levels of the mineral phosphorus ...

  • Glaxo-Pfizer tie-up opens new era in Aids battle 31 Oct 2009 19:53 GMT
    ... forefront of breakthroughs in HIV and Aids treatments in the late 1980s and 1990s with ... the research and development of potential new drugs while also meeting investors' concerns by sharing ... cheaper, generic version of GSK's HIV treatment Abacavir. The new GSK/HIV company will take 19pc ...


1 - 11 / 11

Powered by Newsfeed Maker
NOT SATISFIED WITH THIS ABACAVIR NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
 

Take This Poll

According to the White House, 650,000 jobs were created or saved by $150 billion in stimulus funds. Was it money well spent? (Oct. 30, 2009)



 

BUSINESS PROMOTION SERVICES

EIN Advertising · Place banner ads on EIN News industry specific publications.

EIN Presswire · Upload press releases to the EIN network and have them submitted to leading journalists and decision-makers worldwide.

EIN Global Events · Reach industry-specific readers and promote events, conferences or exhibitions.

EIN Business Directory · Present company or service information on highly-visible, industry and geo-specific news pages.

NEWS SERVICES

News Publications · In-depth geopolitical and industry specific news coverage aggregated from 35,000 online outlets. Updated every 15 minutes.

News Alerts · Receive a free selection of the day's top stories hand picked by EIN News editors.

Newsfeed Maker · Integrate customized newsfeeds in any format covering all industry and geopolitical topics, updated every 15 minutes.

EIN Presswire · Upload press releases to the EIN network and have them submitted journalists and decision-makers worldwide.

Inbox Robot · Customized newsletters delivered by e-mail. Search a news index monitoring thousands of trusted media sources.

COMPANY BACKGROUND

About EIN News · Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become the largest digital news provider in Europe.

Member List · See the partial member list and join a community of professionals from private industry, institutions, and governments that rely on EIN as a critical source for research, breaking news and media services.